Item 2.02. Results of Operations and Financial Condition.
On January 11, 2021, AnaptysBio, Inc., a Delaware corporation ("AnaptysBio"),
presented certain preliminary, unaudited financial information in connection
with a presentation (the "Presentation") at the J.P. Morgan Healthcare
Conference, including that AnaptysBio expects to report that it had cash and
cash equivalents and investments of approximately $410 million as of December
31, 2020.
AnaptysBio's audited financial statements for the fiscal year ended December 31,
2020 are not yet available. Accordingly, the preliminary financial information
included in the Presentation is an estimate subject to the completion of
AnaptysBio's financial closing procedures and any adjustments that may result
from the completion of the audit of AnaptysBio's financial statements. The
preliminary financial information may differ materially from the actual results
that will be reflected in AnaptysBio's audited financial statements when they
are completed and publicly disclosed. Additional information and disclosures
would be required for a more complete understanding of AnapytsBio's financial
position and results of operations as of December 31, 2020.
The information in this Item 2.02 shall not be deemed to be "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section or Sections 11 and 12(a)(2) of the
Securities Act of 1933, as amended. The information contained in this Item 2.02
shall not be incorporated by reference into any registration statement or other
document filed by AnaptysBio with the SEC, whether made before or after the date
of this Current Report on Form 8-K, regardless of any general incorporation
language in such filing (or any reference to this Current Report on Form 8-K
generally), except as shall be expressly set forth by specific reference in such
filing.
Item 7.01. Regulation FD.
AnaptysBio is furnishing the Presentation, a full copy of which is attached
hereto as Exhibit 99.1.
The information furnished with this report, including Exhibit 99.1, shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities
of that section, nor shall it be deemed incorporated by reference into any other
filing under the Exchange Act or the Securities Act of 1933, as amended, except
as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 AnaptysBio Presentation, dated January 2021.
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the
inline XBRL document).
--------------------------------------------------------------------------------
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the
meaning of the U.S. Private Securities Litigation Reform Act of 1995 and other
federal securities laws. Any statements contained herein that do not describe
historical facts, including, but not limited to, statements regarding
AnaptysBio's expected cash, cash equivalents and investments as of December 31,
2020, are forward-looking statements that involve risks and uncertainties that
could cause actual results to differ materially from those discussed in such
forward-looking statements. Such risks and uncertainties include, among others,
the risks identified in AnaptysBio's filings with the Securities and Exchange
Commission ("SEC"), including its Quarterly Report on Form 10-Q for the quarter
ended September 30, 2020, filed with the SEC on November 4, 2020, and subsequent
filings with the SEC. Any of these risks and uncertainties could materially and
adversely affect AnaptysBio's results of operations, which would, in turn, have
a significant and adverse impact on AnaptysBio's stock price. AnaptysBio
cautions you not to place undue reliance on any forward-looking statements,
which speak only as of the date they are made. AnaptysBio undertakes no
obligation to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date they were made or to reflect
the occurrence of unanticipated events.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses